Trying to conceive can become emotionally exhausting when each month brings another unanswered question. The best tests for female infertility are not a one-size-fits-all checklist. A thoughtful evaluation identifies where conception may be getting interrupted – ovulation, egg supply, the fallopian tubes, the uterus, pelvic anatomy, or sometimes a partner-related factor – so treatment can be targeted rather than delayed.
For most women under 35, an infertility assessment is appropriate after 12 months of regular unprotected intercourse without pregnancy. For women 35 and older, it is generally sensible to seek evaluation after six months. Earlier assessment is advisable for irregular or absent periods, known endometriosis, prior pelvic infection or pelvic surgery, recurrent pregnancy loss, severe pelvic pain, or a history that raises concern about the fallopian tubes or ovaries.
There Is No Single Best Test for Female Infertility
Fertility depends on several events happening in the right sequence: an egg must develop and be released, sperm must reach it, the fallopian tube must be open and functional, and the embryo must implant in a healthy uterine lining. Testing should follow your symptoms, age, cycle pattern, medical history, and how long you have been trying.
A specialist consultation is often the most valuable first step. It should cover menstrual regularity, pain with periods or intercourse, previous pregnancies, miscarriages, contraception history, sexually transmitted infections, prior abdominal or pelvic surgery, medications, and family history. This conversation helps prevent unnecessary testing while ensuring important clues are not missed.
Infertility is also a couple’s diagnosis. A semen analysis for the male partner is commonly arranged early in the process because sperm factors contribute to many cases of difficulty conceiving. Testing both partners promptly can save time and avoid placing the entire burden of investigation on one person.
Tests That Confirm Whether Ovulation Is Happening
Regular monthly periods often suggest ovulation, but they do not prove it. Ovulatory problems are more common with polycystic ovary syndrome (PCOS), thyroid disorders, significant weight changes, high stress, excessive exercise, and elevated prolactin levels.
Mid-luteal progesterone testing
A blood progesterone test can help confirm that ovulation has occurred. The timing matters more than a fixed calendar date. It is usually taken about seven days before the expected next period, rather than automatically on day 21. For women with longer or irregular cycles, individualized timing gives a more meaningful result.
Hormone blood tests
Blood tests may include thyroid-stimulating hormone, prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and androgens such as testosterone. These tests are selected according to the clinical picture. For example, irregular periods, acne, increased facial hair, or weight changes may point toward PCOS or another hormonal cause.
Hormone results should never be interpreted in isolation. A result can vary with cycle day, medications, and the laboratory used. The goal is not simply to label a number as normal or abnormal, but to understand whether hormones are affecting ovulation or the uterine environment.
Ovarian Reserve Testing: What It Can and Cannot Tell You
Ovarian reserve refers to the estimated number of eggs remaining in the ovaries. It is especially relevant for women over 35, those with prior ovarian surgery, endometriosis, chemotherapy exposure, or a family history of early menopause.
The most common assessments are anti-Mullerian hormone (AMH), antral follicle count on ultrasound, and sometimes early-cycle FSH and estradiol. AMH can be measured at most times in the cycle, while an antral follicle count is performed using a transvaginal ultrasound to count small resting follicles in each ovary.
These are useful planning tests, particularly when considering fertility treatment or fertility preservation. However, ovarian reserve does not measure egg quality directly, guarantee natural conception, or predict exactly how quickly pregnancy will occur. Age remains one of the strongest indicators of egg quality. A low AMH result deserves an informed discussion, not panic, while a reassuring result should not be used as a reason to postpone assessment when there are clear symptoms or risk factors.
Pelvic Ultrasound: A Close Look at the Uterus and Ovaries
A transvaginal pelvic ultrasound is among the most informative early investigations. It can assess the shape and size of the uterus, the thickness and appearance of the endometrium, ovarian follicle development, and conditions that may affect fertility.
Ultrasound may detect uterine fibroids, ovarian cysts, polycystic ovarian appearance, adenomyosis, hydrosalpinx, and some signs of endometriosis. It can also identify polyps or fibroids that distort the uterine cavity, which may interfere with implantation or increase miscarriage risk.
Not every fibroid needs treatment before pregnancy. The location, size, number, and effect on the uterine cavity matter far more than the word “fibroid” alone. Likewise, an ovarian cyst may be harmless, temporary, or clinically significant depending on its type and appearance. A specialist should weigh symptom relief, fertility goals, and the need to protect healthy ovarian tissue before recommending surgery.
Fallopian Tube Tests Are Essential When Tubal Disease Is Possible
Even with normal ovulation and a healthy uterus, pregnancy cannot occur naturally if both fallopian tubes are blocked. Tubal problems can arise after pelvic inflammatory disease, previous ectopic pregnancy, abdominal surgery, appendicitis, endometriosis, or adhesions.
Hysterosalpingogram (HSG)
An HSG is an X-ray procedure in which contrast dye is placed through the cervix to outline the uterine cavity and show whether dye travels through the tubes. It is typically scheduled after menstruation but before ovulation. The test can reveal a blocked tube, a hydrosalpinx, or an irregularity within the uterine cavity.
Some women experience cramping during an HSG, although this is often brief. It is a useful first-line tubal test, but a result suggesting blockage at the part of the tube nearest the uterus may occasionally reflect temporary spasm. Further assessment may be needed before making major treatment decisions.
Saline infusion sonography and contrast ultrasound
Saline infusion sonography uses fluid and ultrasound to examine the uterine cavity more closely. It can be particularly helpful for identifying polyps, small submucosal fibroids, adhesions, or a uterine septum. In some centers, ultrasound contrast may also be used to assess tubal patency without X-ray exposure.
The right choice depends on what needs clarification. An HSG may provide a broad view of the tubes, while saline infusion imaging can give better detail of the uterine cavity.
When Hysteroscopy or Laparoscopy Is Appropriate
Hysteroscopy involves passing a thin camera through the cervix to examine the inside of the uterus. It may be recommended if imaging suggests a polyp, adhesions, a septum, or a cavity-distorting fibroid. One advantage is that certain problems can sometimes be treated during the same procedure, such as removing a polyp or dividing scar tissue.
Laparoscopy is keyhole surgery used to inspect the pelvis directly. It is not a routine first test for every woman with infertility because it involves anesthesia and recovery. However, it can be appropriate when symptoms or imaging raise concern for endometriosis, pelvic adhesions, tubal damage, or ovarian endometriomas.
This distinction matters for women with severe period pain, deep pain during intercourse, bowel or bladder symptoms around menstruation, or previous scans that suggest endometriosis. Superficial disease may not always be visible on ultrasound, while deep infiltrating endometriosis can affect the ovaries, tubes, uterus, bowel, bladder, and pelvic nerves. In these situations, expert imaging and carefully planned fertility-preserving surgery can be more valuable than repeated basic testing.
Advanced minimally invasive approaches, including 3D laparoscopy and robotic surgery, may allow precise treatment of complex pelvic disease while minimizing trauma to surrounding tissues. Surgery is not automatically the best path for every patient. The decision should consider pain, disease extent, ovarian reserve, age, tubal status, and whether natural conception, IVF, or fertility preservation is most appropriate.
Genetic and Additional Testing in Selected Situations
Some investigations are only useful when there is a clear reason to order them. Genetic testing may be considered with recurrent pregnancy loss, known inherited conditions, early menopause, or particular family histories. Screening for diabetes, autoimmune disease, or infections may also be appropriate in selected cases.
Tests marketed as broad fertility panels can be tempting when answers feel urgent. Yet more testing is not always better testing. Unvalidated immune tests, routine endometrial “receptivity” tests, and extensive thrombophilia panels may add cost and anxiety without changing care for many patients. A good fertility workup is comprehensive where evidence supports it and restrained where it does not.
The most useful next step is a consultation that brings your history, examination, ultrasound findings, hormone results, and fertility priorities into one clear plan. You deserve answers that are medically precise, honest about uncertainty, and focused on protecting both your health and your future choices.